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Loss of Tyrosine Aminotransferase may Contribute to the Pathogenesis of Hepatocellular 
Carcinoma. X.Y. Guan, Y.W. Xie, J.S.T. Sham. Dept Clinical Oncology, Univ Hong Kong, 
Hong Kong, China. 
   Loss of material at chromosome arm 16q is one of the most frequent alterations in 
hepatocellular carcinoma (HCC) detected by comparative genomic hybridization and loss of 
heterozygosity studies. It suggests that the frequent deleted region at 16q may contain a tumor 
suppressor gene. cDNA subtraction strategy was applied to isolate down-regulated gene at 16q. 
cDNAs from the surrounding non-tumor liver tissue was subtracted with cDNAs from its 
matched primary HCC tumor and a gene at 16q22, tyrosine aminotransferase gene (TAT), was 
isolated. RNA expression of the TAT gene in 8 primary HCC tumors with 16q deletion was 
analyzed by northern blot hybridization and reverse transcriptase-polymerase chain reaction. 
Absence and marked reduction expression of TAT gene was detected in 5 and 2 tumors, 
respectively, as compared with tumor surrounding liver tissues. Homo-deletion of genomic 
DNA sequence of TAT gene was observed in two cases detected by PCR. Tyrosine 
aminotransferase is the rate-limiting enzyme for the tyrosine catabolic pathway and the 
deficiency of TAT gene may result in elevation of tyrosine level. Prolonged elevation of 
intracellular tyrosine concentrations may disrupt normal functions of hepatocytes and initiate 
local inflammatory responses, leading to liver diseases including HCC. Therefore, loss of TAT 
gene may contribute to the pathogenesis of HCC.  
 
